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Abstract
Background: To allow better assessment of patients’ individual competencies for self-management, the Patient
Activation Measure (PAM) has been developed in the USA. Because the American studies have shown the PAM to
be a valuable tool, several European countries have translated the instrument into their native languages (Danish,
Dutch, German, Norwegian). The aim was to compare the psychometric properties in studies from the different
countries and establish whether the scores on the PAM vary between the studies.
Methods: Data from the four separate studies were subjected to the same data cleaning procedures and statistical
analyses. The psychometric properties of the instruments were established with measures of data quality and scale
structure. The mean patient activation score and distribution across four predefined activation levels were described
and the differences between the four studies were tested with ANOVA (unadjusted and adjusted) followed by a
post-hoc Tukey HSD test and the Pearson chi-squared test respectively.
Results: The total N of the four studies was 5184. The percentage of missing values was low in all datasets,
confirming the good quality of the datasets. Factor analyses revealed moderate to strong factor loadings on the
first factor in all datasets. Cronbach’s α was high for all version, ranging from .80 (German) to .88 (Dutch). Item-rest
correlations varied between .32 and .66, indicating a moderate to strong correlation of the individual items to the
sum scale.
Both the mean PAM score and the distribution across activation levels differed between the four datasets. After
adjustment of the PAM score, patients in Norway in particular had a higher patient activation level.
Conclusions: The European translations of PAM-13 (into Danish, Dutch, German and Norwegian) resulted in four
instruments with good psychometric capabilities for measuring patient activation. The mean PAM score and the
distribution across activation levels differed between the four datasets.
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Background
As people are generally living longer and medical treat-
ment possibilities have improved, numbers of chronically
ill patients are rising. In 2012, 29 % of men and 33 % of
women in Europe reported having one or more chronic
diseases or long-term health problems [1]. These percent-
ages are higher for the elderly and for people with lower
levels of education. The growing numbers of chronically
ill people are placing a heavy burden on the healthcare
system resources of western countries, both with respect
to costs and manpower.
Patients with chronic illnesses have to cope with their
disease and its consequences every day. This is also re-
ferred to as self-management. Lorig defines self-
management as ‘learning and practicing skills necessary
to carry on an active and emotionally satisfying life in
the face of a chronic condition’ [2]. She discerns three
different types of self-management tasks: medical man-
agement, role management, and emotional manage-
ment [3]. Patients who are more active in self-
management generally have better health outcomes and
report a better health-related quality of life [4–6].
There are also studies that show an association between
better self-management and lower healthcare costs [6,
7]. The importance of self-management is widely recog-
nised, but nevertheless many barriers exist in the im-
plementation of self-management behaviour. These
barriers can be categorised as individually based (e.g.
low skills, motivation and self-confidence, emotional
distress), relationship-based (e.g. lack of social support)
and environmentally based barriers (e.g. negative stim-
uli for healthy behaviour in society) [8].
To allow better assessment of patients’ individual com-
petencies for self-management, Hibbard et al. developed
and tested the Patient Activation Measure (PAM) in
2004 [9, 10]. The instrument was first developed in a
longer version (22 questions) and slightly adapted later
to a shorter version with 13 items. This version of the
PAM is currently being used. Patient activation is de-
fined as ‘an individual’s knowledge, skills, and confidence
for managing their health and healthcare’ [10]. The
PAM has been extensively validated and researched, al-
though this was predominantly done in the USA. A re-
cent report by Hibbard and Gilburt [11] provides an
overview of the concept and measurement instrument,
describes the positive relationship between patient acti-
vation and several health behaviours and outcomes, il-
lustrates how the measurement instrument can be used
and states the considerations as to why and how the
PAM should be implemented.
The PAM scores have been used to divide people into
one of four progressively higher activation levels, from
passive and lacking knowledge and skills in dealing with
health and healthcare in level 1 to active, generally well-
informed and competent in level 4 (Table 6) [11, 12]. Sev-
eral American studies have shown that care tailored to a
patient’s activation level as measured with the PAM re-
sulted in improved values on clinical indicators, better ad-
herence to medication regimens and a reduction in
hospitalisations and emergency department visits [13, 14].
Also, patient activation appeared to be modifiable and in-
creases in activation have been found to be followed by
improvement in self-management behaviour [14, 15].
Because the studies in the USA have shown the PAM
to be a valuable tool, researchers in several European
countries have translated the instrument into their na-
tive languages and validated it in a European setting
[16–19]. In this article, data from different studies using
the Danish, Dutch, German and Norwegian versions of
the PAM are compared with each other and where pos-
sible with the original data from the USA.
The main aim of this study is to compare the psycho-
metric properties of PAM in surveys from the different
countries and compare the mean PAM score and the
distribution between the four PAM levels between the
studies.
Methods
The Patient Activation Measure
The 13-item version of the PAM was used in all four
European studies [10]. The 13 items are: (1) When all is
said and done, I am the person who is responsible for tak-
ing care of my health; (2) Taking an active role in my own
health care is the most important thing that affects my
health; (3) I am confident I can help prevent or reduce
problems associated with my health; (4) I know what each
of my prescribed medications do; (5) I am confident that I
can tell whether I need to go to the doctor or whether I
can take care of a health problem myself; (6) I am
confident that I can tell a doctor concerns I have even
when he or she does not ask; (7) I am confident that I can
follow through on medical treatments I may need to do at
home; (8) I understand my health problems and what
causes them; (9) I know what treatments are available for
my health problems; (10) I have been able to maintain
(keep up with) lifestyle changes, like eating right or exer-
cising; (11) I know how to prevent problems with my
health; (12) I am confident I can figure out solutions when
new problems arise with my health: (13) I am confident
that I can maintain lifestyle changes, like eating right and
exercising, even during times of stress. All items have five
possible responses with scores ranging from 0 to 4; (1) dis-
agree strongly, (2) disagree, (3) agree, (4) agree strongly or
(0) not applicable. We calculated the mean score for the
PAM items, leaving out items left blank or deemed not ap-
plicable by the respondents. Thus if the respondent had
answered e.g. 11 items, the average of these was calcu-
lated. Participants who filled out fewer than seven
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questions were excluded, as were participants who an-
swered all items with ‘disagree strongly’ or ‘agree strongly’
because these response sets were considered highly un-
likely. The mean score was transformed into a standar-
dised activation score ranging from 0 to 100 (the PAM
score), based on a conversion table provided by the devel-
opers for data collected before 2014. The PAM score was
then converted into one of the four levels of patient acti-
vation [12].
Studies included
In the Danish study (N = 328), patients with different
types of dysglycaemia were studied. In the Netherlands,
the study included patients with a chronic illness who
are taking part in an ongoing Dutch National Panel of
People with Chronic Illness or Disability (NPCD) (N =
1829). In the study in Germany, adult patients from
multiple primary care centres (in Germany, Austria and
Switzerland) were included (N = 488). The Norwegian
study included a sample of patients attending a range of
different self-management courses provided by hospitals
for persons with chronic conditions (N = 2539). The re-
sults from the USA were taken from the 13-item valid-
ation study [10].
The demographic characteristics of the four samples
are shown in Table 1. The respondents of the German
sample were relatively young (average age 54) and the
Danish relatively old (average age 65). There were rela-
tively more men in the Danish sample than the other
groups and there were some differences in self-reported
health status with the Norwegian and Dutch sample
reporting worse self-reported health.
Statistical analyses
Data from the four separate studies were combined and
subjected to the same procedures of data cleaning and
data management. The total N of the four studies was
5184. Given that the same data cleaning procedures
were now used throughout, there are minor differences
between the results presented in this article and in the
previous Danish [16] and German [18] publications.
We then analysed the data from each country separ-
ately. The psychometric properties of the instruments
were established with measures of data quality (percent-
age of missing data and of ‘non applicable’ answers) and
scale structure (factor analyses, Cronbach’s α, item rest
correlations). We performed a principal factor analysis
(unrotated) for each dataset to see whether the PAM
consists of one factor as in the original study. The cut-
off point for the eigenvalue was ≥ 1. We then determined
Cronbach’s alpha and the item rest correlations for the
factors. We considered a scale as being sufficiently in-
ternally consistent if Cronbach’s alpha was ≥ 0.70. An
item rest correlation of ≥ 0.50 was considered strong, r ≥
0.30 moderate and r ≥ 0.10 weak.
The mean PAM score and distribution for each level
were described for each country. With the Pearson chi-
squared test, we determined whether the distribution for
each level varied between the four datasets. We per-
formed an ANOVA (unadjusted and adjusted for age,
sex and self-reported health status) followed by a post-
Table 1 Demographic characteristics
Variable Danish Dutch German Norwegian USA
Mean age (SD) 62.2 (7.1) 58.9 (15.9) 54.4 (16.5) 58.3 (12.5) Range 45 - 97
Age groups (N) 328 1829 488 2539 1469
Younger than 45 3 (1 %) 378 (21 %) 132 (27 %) 353 (14 %) 0 (0 %)
45–54 years 48 (15 %) 239 (13 %) 110 (23 %) 485 (19 %) 512 (38 %)
55–64 years 143 (44 %) 476 (26 %) 96 (20 %) 800 (32 %) 398 (28 %)
65–74 years 128 (39 %) 428 (23 %) 87 (18 %) 583 (23 %) 290 (20 %)
75 and older 6 (2 %) 308 (17 %) 63 (13 %) 318 (13 %) 188 (15 %)
Sex (N) 328 1829 487 2284 1469
Male 183 (56 %) 800 (44 %) 240 (49 %) 961 (42 %) 543 (37 %)
Female 145 (44 %) 1029 (56 %) 247 (51 %) 1323 (58 %) 926 (63 %)
Health status (N) 320 1823 480 2431
Excellent 12 (4 %) 36 (2 %) 80 (17 %) 31 (1 %) 255 (18 %)
Very good 79 (25 %) 192 (11 %) 188 (39 %) 277 (11 %) 465 (31 %)
Good 181 (57 %) 1005 (55 %) 121 (25 %) 983 (40 %) 411 (28 %)
Fair 42 (13 %) 525 (29 %) 78 (16 %) 867 (36 %) 236 (16 %)
Poor 6 (2 %) 65 (4 %) 13 (3 %) 273 (11 %) 102 (7 %)
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hoc Tukey HSD test to determine whether the mean




The mean scores along with the percentage of miss-
ing data and of ‘non applicable’ answers from the
four studies on the 13 items are shown in Table 2. In
the German study, the answer category ‘not applic-
able’ (NA) was not used. In general a very low per-
centage of missing values was reported, between 0.0
and 3.2. This confirms the good quality of these
datasets.
Explorative factor analysis led to the identification
of one factor with an eigenvalue of ≥ 1 in the Dutch,
German and Norwegian versions of the questionnaire
(as in the original American one). In the Danish data,
two factors with eigenvalues of ≥ 1 were identified.
Items 1, 2 and 3 of the PAM-13 had a higher loading
on factor 2 than factor 1. However, these items also
had a sufficient factor loading (≥0.40) on factor 1, as
did the remaining items. Therefore, as in the other
studies, we determined the internal consistency of the
first factor consisting of all 13 items in the Danish
study.
Cronbach’s α for all four versions of the PAM was
similar and high, varying from .80 (German) to .88
(Dutch) (Table 3). This confirms the good internal
consistency of the instruments. Item-rest correlations
vary between .32 and .66 in all versions of the PAM,
indicating a moderate to strong correlation of the indi-
vidual items to the sum scale.
Patient activation scores
The mean scores of the items in all versions of the
PAM varied between 2.62 and 3.82 (Danish 2.83–3.60,
Dutch 2.62–3.32, German 2.90–3.74, Norwegian 2.81–
3.82, Table 2). We looked at the distribution of pa-
tients across PAM levels. This distribution differed
significantly between the four datasets (p < 0.001). The
percentage of patients in the lowest two (i.e. least acti-
vated) levels of the PAM (see Table 6) was especially
high in the Netherlands (37 %). In the other countries,
18 % (German-speaking group) to 22 % (Danish-
speaking group) of the patients belonged to these two
levels (Table 4).
We have presented the comparison between the mean
PAM scores of the four versions of the PAM in Table 5,
both unadjusted and adjusted for age, sex and self-
reported health.
While the unadjusted mean PAM score in the
Netherlands is similar to the one in the USA, the
PAM scores in the other countries were higher. Fur-
thermore the PAM scores between the different stud-
ies differed significantly (p < 0.05) except between the
German and the Norwegian data (p = 0.627).
When adjusted for age, sex and self-reported global
health, all PAM scores differ significantly from each
other, except between the Danish and the Dutch data
(p = 0.828) and the Danish and the German data (p =
0.441). This means that the Norwegian patients had a
higher activation level than all other groups and that




Danish Dutch German Norwegian
Mean (SD) % MV % NA Mean (SD) % MV % NA Mean (SD) % MV % NA Mean (SD) % MV % NA
1 3.60 (0.53) 0.0 0.6 3.32 (0.71) 1.0 1.7 3.65 (0.57) 0.8 - 3.67 (0.57) 0.6 0.1
2 3.48 (0.57) 0.3 0.3 3.20 (0.69) 3.2 12.9 3.55 (0.59) 1.2 - 3.82 (0.47) 0.3 0.4
3 3.49 (0.59) 0.6 0.9 3.10 (0.73) 1.5 5.1 3.56 (0.59) 0.2 - 3.24 (0.70) 1.3 0.5
4 3.14 (0.66) 3.1 17.4 3.20 (0.66) 0.4 5.1 3.74 (0.52) 0.6 - 3.24 (0.78) 1.1 10.2
5 2.99 (0.72) 0.6 8.5 3.24 (0.60) 0.5 0.7 3.39 (0.67) 0.6 - 3.20 (0.72) 0.8 1.3
6 3.26 (0.66) 0.3 4.6 3.29 (0.61) 0.9 0.9 3.64 (0.60) 0.2 - 3.50 (0.67) 0.5 0.4
7 3.37 (0.55) 0.3 2.7 3.30 (0.57) 1.6 17.6 3.01 (0.91) 1.8 - 3.58 (0.65) 1.0 5.5
8 3.28 (0.59) 0.0 7.6 3.23 (0.67) 0.9 2.7 3.08 (0.78) 0.6 - 3.15 (0.80) 0.4 0.8
9 3.02 (0.67) 0.3 17.1 3.10 (0.67) 1.4 4.3 2.90 (0.85) 1.4 - 2.81 (0.84) 0.7 1.1
10 3.00 (0.68) 0.6 5.5 3.03 (0.66) 1.8 12.9 3.15 (0.70) 1.0 - 3.26 (0.69) 1.1 3.4
11 3.08 (0.57) 0.6 8.8 2.95 (0.70) 1.0 6.8 3.22 (0.66) 1.0 - 2.99 (0.82) 1.1 0.8
12 2.94 (0.60) 0.3 16.5 2.62 (0.75) 1.2 8.0 2.97 (0.83) 0.6 - 2.82 (0.75) 3.0 1.7
13 2.83 (0.74) 0.0 11.9 2.84 (0.70) 1.0 7.4 2.90 (0.80) 0.4 - 3.08 (0.73) 2.7 1.3
%MV = percentage of missing values
%NA = percentage not applicable; category not used in German studies
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the German-speaking patients had a higher activation
level than the Dutch patients.
Discussion
The results of this study confirmed the results of the
earlier published studies [16–19] that the translations
of the PAM-13 (into Danish, Dutch, German and
Norwegian) resulted in four instruments with good psy-
chometric capabilities for measuring patient activation.
The psychometric properties of the PAM were similar
across the different studies.
The unadjusted mean scores on the PAM did differ
between the four studies. On average, the Dutch patients
had the lowest mean PAM score at 61.2, while the
German-speaking patients had the highest mean PAM
score at 67.2. Danish and Norwegian patients were posi-
tioned in the middle. The differences between the mean
scores on the four questionnaires can partly be explained
by the variation in the samples and recruitment proce-
dures. While Denmark, the Netherlands and Norway ad-
ministered their questionnaires to older, chronically ill
patients, the German-speaking respondents were youn-
ger (50 % < 55 years) and recruited at primary care cen-
tres. After correcting for age, sex and self-reported
health, the mean scores still differed between the four
versions of the PAM. But now, the Norwegian patients
had a higher PAM score than the other three groups.
The distribution across the four PAM levels was some-
what different, with the percentage of patients in the
lowest two levels of the PAM (see Table 6) being espe-
cially high in the Netherlands (37 %). It might be that
the distribution is different due to the fact that the coun-
tries included here have different cultures and healthcare
systems. Using focus groups, Hibbard et al. established
that people in the four patient activation levels differed
in terms of self-management behaviour [9]. On the basis
of their research, the developers of the PAM established
the cut-off points of the four groups [12]. When trans-
lating and validating the PAM in another language and
country, it is also sensible to examine whether the four
levels are also associated with different behaviours or
that the cut-off points should be placed elsewhere. This
might have important implications when the PAM score
is used to tailor healthcare to a patient’s activation level
or to improve someone’s activation level.
The fact that a lower (poorer) activation score was found
in the Netherlands is striking, given that the Netherlands
scored best in a European comparative study on health lit-
eracy in eight countries (HLS-EU), with a percentage of
28.7 % people with limited health literacy, whereas this
same percentage was 46.3 in Germany and 56.4 in Austria
[20]. Denmark and Norway were not included in that
study. Taken together, it seems that the people in the
Netherlands perform better than the populations in these
German-speaking countries with respect to accessing, un-
derstanding, appraising and applying health-related infor-
mation (the HLS-EU definition of health literacy) but that
they are more likely to perceive themselves as lacking the
psychosocial skills such as motivation and self-confidence
(central parts of the PAM score), which are equally import-
ant for self-management, if not indeed more important.
Earlier studies already demonstrated that the overlap be-
tween health literacy (when defined in a functional way)
and patient activation is limited [21–23]. However, with a
broader conceptualisation of health literacy that includes
psychosocial and contextual variables, as is being done in
Table 3 Factor analyses and reliability
Test Danish Dutch German Norwegian
Factor 1 Factor 2a Factor 1 Factor 1 Factor 1
Percentage of explained variance 69.5 % 24.4 % 85.4 % 90.8 % 96.7 %
Factor loadings 0.41–0.65 |0.01|–|0.63| 0.47–0.72 0.32–0.63 0.44–0.64
Cronbach’s alpha 0.86 0.88 0.80 0.84
Item-rest correlations 0.44–0.60 0.46–0.66 0.32–0.57 0.37–0.60
aThe first three items had a higher loading for factor 2 than factor 1, but the loading for factor 1 was still >0.40. We therefore only performed the reliability
analyses for factor 1 containing all 13 items














64.1 61.2 67.2 66.3 61.9
Activation level
Level 1 29 (9 %) 313 (17 %) 45 (9 %) 283 (11 %)
Level 2 41 (13 %) 357 (20 %) 44 (9 %) 235 (9 %)
Level 3 125 (38 %) 588 (32 %) 127 (26 %) 640 (25 %)
Level 4 133 (41 %) 571 (31 %) 272 (56 %) 1381 (54 %)
Table 5 Comparison of mean activation score (standard error in
parentheses) between countries with and without taking
account of age, sex and self-reported health status
PAM score Danish Dutch German Norwegian F
PAM unadjusted 64.1 (0.80) 61.2 (0.34) 67.2 (0.66) 66.3 (0.29) 49.66*
PAM adjusted 62.1 (0.79) 61.4 (0.33) 63.7 (0.68) 67.4 (0.30) 63.42*
*p < 0.001
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the Health Literacy Questionnaire (HLQ) [24], the overlap
will inevitably increase.
The main limitation of this study is that it compares
different studies with different inclusion criteria, making
the samples different with respect to e.g. age and health
status. This may have led to differences between the re-
ported scores. However, even after adjustment for these
variables, the majority of the variation between the
scores remained.
Another limitation is the fact that the answer categor-
ies were different for the dataset of the German version
(leaving out the ‘not applicable’ option). This might have
led to somewhat higher mean scores on the German ver-
sion of the PAM, thus exaggerating the differences.
The strength of this study is that we used the same
methods for data cleaning and data management and
statistical analyses for the data from these four European
studies. We were therefore able to assess and test simi-
larities and differences more accurately between the psy-
chometric aspects of the instruments and between the
scores.
In this study, we looked at psychometric properties
such as data quality and scale structure. These are
methods used in the classical test theory to get insights
into the validity and reliability of an instrument. An in-
teresting next step would be to use Item Response The-
ory (IRT) and Differential Item Function (DIF) analyses
to assess whether different items present as more or less
“difficult” to different people of different countries.
Conclusions
The European translations of the PAM (into Danish,
Dutch, German and Norwegian) resulted in four instru-
ments with good psychometric capabilities for measur-
ing patient activation. The mean PAM scores and the
distribution across activation levels differed between the
four datasets.
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